Intractable and Rare Diseases Research

Aims & Scope

Intractable & Rare Diseases Research is one of a series of peer-reviewed journals of the International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) Group and is published quarterly by the International Advancement Center for Medicine & Health Research Co., Ltd. (IACMHR Co., Ltd.) and supported by the IRCA-BSSA, Shandong Academy of Medical Sciences, and Shandong Rare Disease Association.

Intractable & Rare Diseases Research devotes to publishing the latest and most significant research in intractable and rare diseases.

Articles cover all aspects of intractable and rare diseases research such as molecular biology, genetics, clinical diagnosis, prevention and treatment, epidemiology, health economics, health management, medical care system, and social science in order to encourage cooperation and exchange among scientists and clinical researchers.

Intractable & Rare Diseases Research publishes Original Articles, Brief Reports, Reviews, Policy Forum articles, Case Reports, News, and Letters on all aspects of the field of intractable and rare diseases research.

All contributions should seek to promote international collaboration.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.6
2024	1.10

Journal Rank

Year	Value
2024	14248

Journal Citation Indicator

Year	Value
2024	1358

SJR (SCImago Journal Rank)

Year	Value
2024	0.382

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	34

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Modeling fragile X syndrome in the <i>Fmr1</i> knockout mouse

  Citation: 217

  Authors: Tatiana M., Prescott T., Jill L., Jacqueline N.

• Fragile X spectrum disorders

  Citation: 158

  Authors: Reymundo, Carolina Alba, Randi J

• Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China

  Citation: 138

  Authors: Xianping, Zhiqiang, Zhibin, Haixiang, Xinhao

• Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations

  Citation: 108

  Authors: Buraa, Khawla, C. Stephen

• Cardiac manifestations in Behcet's disease

  Citation: 104

  Authors: Selami, Husnu, Sinan, Arif

• A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management

  Citation: 103

  Authors: Jing, Jing, Wing Ting, Ling

• Current status of treatment for primary effusion lymphoma

  Citation: 101

  Authors: Seiji, Hiroki, Mihoko

• Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa

  Citation: 95

  Authors: Ellie, John A.

• Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment

  Citation: 93

  Authors: Barbara, Ivan, Anna, Elisa, Veronica, Valerio, Marina, Stefano, Annamaria

• Methylmalonic acidemia: Current status and research priorities

  Citation: 89

  Authors: Xiaoyan, Yazhou, Jinxiang

---